New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
10:10 EDTORPNBio Blast Pharma opens at $10.90, IPO priced at $11.00
Bio Blast Pharma priced 3.2M shares at $11.00. Oppenheimer and Roth Capital acted as joint book running managers for the offering.
News For ORPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
08:07 EDTORPNBio Blast Pharma issued patent for novel fusion protein
Bio Blast Pharma announced it has received a Notice of Patent Issuance for patent no. 8,912,147 from the United States Patent and Trademark Office for a composition-of-matter patent for its novel fusion protein for Friedrich's Ataxia that is built on its mitochondrial protein replacement platform.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use